Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




HLA Genes Have Role in Preterm Delivery

By HospiMedica staff writers
Posted on 16 Sep 2004
The transmission of human leukocyte antigen (HLA) genes play a significant role in the risk of preterm delivery, according to a new study published in the September 2004 issue of Obstetrics and Gynecology.

The study involved a total of 234 subjects from 78 families with early preterm deliveries (35 weeks or less) and 60 subjects from 20 families with full-term births. More...
Cheek cells were collected from first-born preterm cases and their parents to determine HLA-B and DRB1 gene type and the transmission of parental alleles to the offspring. The aim of the study was to determine whether parentally shared HLA alleles are more likely than expected to be transmitted to preterm children.

Compared to offspring who did not receive any parentally shared HLA alleles, offspring who received the alleles from both parents had more than a five-fold increased risk of preterm delivery. Offspring who received the HLA allele only from the mother also had increased risk of preterm delivery, while offspring who received the HLA allele only from the father did not have increased risk. This is the first time that parental HLA makeup has been linked to preterm delivery.

"There is increasing evidence that successful pregnancy requires healthy immunological interaction between parents and between mother and fetus,” said lead author De-Kun Li, M.D., Ph.D., senior research scientist at Kaiser Permanente (Oakland, CA, USA). "HLA alleles control immune response. Abnormal immune response due to HLA mismatch among mother, father, and the fetus could lead to unsuccessful pregnancy.”

Dr. De-Kun suggests a way may be found to detect those fetuses at high risk of preterm delivery by testing parental HLA types. Monitoring those high-risk pregnancies could help prevent preterm delivery.




Related Links:
Kaiser Permanente

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.